H. A. Valkenburg

7.1k total citations · 1 hit paper
111 papers, 5.4k citations indexed

About

H. A. Valkenburg is a scholar working on Rheumatology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, H. A. Valkenburg has authored 111 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Rheumatology, 24 papers in Epidemiology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in H. A. Valkenburg's work include Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (14 papers) and Osteoarthritis Treatment and Mechanisms (11 papers). H. A. Valkenburg is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (18 papers), Systemic Lupus Erythematosus Research (14 papers) and Osteoarthritis Treatment and Mechanisms (11 papers). H. A. Valkenburg collaborates with scholars based in Netherlands, Australia and New Zealand. H. A. Valkenburg's co-authors include Jan P. Vandenbroucke, A. Cats, Jan Schouten, F A van den Ouweland, Diederick E. Grobbee, Albert Hofman, Albert M. van Hemert, R. D. Wigley, K. D. Muirden and Jacqueline C.M. Witteman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

H. A. Valkenburg

109 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations.

1989 668 citations A. Cats, Jan P. Vandenbroucke et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by H. A. Valkenburg

Since Specialization

Citations

This map shows the geographic impact of H. A. Valkenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. A. Valkenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. A. Valkenburg more than expected).

Fields of papers citing papers by H. A. Valkenburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. A. Valkenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. A. Valkenburg. The network helps show where H. A. Valkenburg may publish in the future.

Co-authorship network of co-authors of H. A. Valkenburg

This figure shows the co-authorship network connecting the top 25 collaborators of H. A. Valkenburg. A scholar is included among the top collaborators of H. A. Valkenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. A. Valkenburg. H. A. Valkenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	National database of patients visiting rheumatologists in The Netherlands: the standard diagnosis register of rheumatic diseases. A report and preliminary analysis 1998 ·Lara D. Veeken ·H. S. Miedema, Sjef M. van der Linden, Johannes J. Rasker, H. A. Valkenburg	44
2	Characteristics and Determinants of Sumatriptan-Associated Chest Pain 1997 ·Archives of Neurology ·J. P. Ottervanger, H. A. Valkenburg, Diederick E. Grobbee, Bruno H. Stricker	26
3	Trends in Cancer Incidence and Mortality (Cancer Surveys 19/20) 1995 ·BMJ ·H. A. Valkenburg	9
4	Association of locomotor complaints and disability in the Rotterdam study. 1995 ·Annals of the Rheumatic Diseases ·E Odding, H. A. Valkenburg, D. Algra, (unknown), Diederick E. Grobbee, Albert Hofman	42
5	Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies 1994 ·Journal of Medical Microbiology ·R. J. P. M. Scholten, Betsy Kuipers, H. A. Valkenburg, John R. Dankert, Wendell D. Zollinger, Jan Poolman	106
6	Phenotypic and Genotypic Changes in a New Clone Complex of Neisseria meningitidis Causing Disease in the Netherlands, 1958-1990 1994 ·The Journal of Infectious Diseases ·R. J. P. M. Scholten, Jan Poolman, H. A. Valkenburg, H. A. Bijlmer, J. Dankert, Dominique A. Caugant	44
7	Adverse reactions attributed to sumatriptan 1994 ·European Journal of Clinical Pharmacology ·Jan Paul Ottervanger, Bruno H. Stricker, (unknown), H. A. Valkenburg, Diederick E. Grobbee	39
8	Antibiotic susceptibility of invasive and non-invasive isolates of Haemophilus influenzae from the Gambia, West Africa 1994 ·Journal of Antimicrobial Chemotherapy ·H. A. Bijlmer, L van Alphen, B. M. Greenwood, (unknown), H. A. Valkenburg, J. Dankert	7
9	A population based case‐cohort study of drug‐induced anaphylaxis. 1993 ·British Journal of Clinical Pharmacology ·Melanie M. van der Klauw, (unknown), RM Herings, (unknown), H. A. Valkenburg, (unknown)	71
10	Cardiovascular risk and all-cause mortality; A 12 year follow-up study in The Netherlands 1993 ·European Journal of Epidemiology ·Arno W. Hoes, D. E. Grobbee, H. A. Valkenburg, Jacobus Lubsen, Amy Hofman	34
11	Postmarketing study of cardiovascular adverse reactions associated with sumatriptan. 1993 ·BMJ ·Jan Paul Ottervanger, (unknown), H. A. Valkenburg, Bruno H. Stricker	16
12	INSULIN-LIKE GROWTH FACTOR-1: A PROGNOSTIC FACTOR OF KNEE OSTEOARTHRITIS 1993 ·Lara D. Veeken ·Jan Schouten, F A van den Ouweland, H. A. Valkenburg, S.W.J. Lamberts	53
13	Meningococcal Disease in the Netherlands, 1958-1990: A Steady Increase in the Incidence Since 1982 Partially Caused by New Serotypes and Subtypes of Neisseria meningitidis 1993 ·Clinical Infectious Diseases ·R. J. P. M. Scholten, H. A. Bijlmer, Jan Poolman, Betsy Kuipers, Dominique A. Caugant, L van Alphen, J. Dankert, H. A. Valkenburg	75
14	Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis 1992 ·The Lancet ·Jan T. M. van der Meer, Marc Michel, H. A. Valkenburg, (unknown), J. Thompson, Jan P. Vandenbroucke	226
15	Increased risk of atherosclerosis in women after the menopause. 1989 ·BMJ ·Jacqueline C.M. Witteman, Diederick E. Grobbee, F.J. Kok, Albert Hofman, H. A. Valkenburg	219
16	Childhood leukaemia in The Netherlands, 1973–1986: Temporary variation of the incidence of acute lymphocytic leukaemia in young children 1989 ·British Journal of Cancer ·J.W.W. Coebergh, A van der Does-van den Berg, Elisabeth R. van Wering, H A van Steensel-Moll, H. A. Valkenburg, Mars B. vanʼt Veer, (unknown), G E van Zanen	27
17	Early Prediction of Primary Hypertension: An Epidemiological Approach 1988 ·International Journal of Epidemiology ·(unknown), D. E. Grobbee, Albert Hofman, H. A. Valkenburg	6
18	The Association between Ankylosing Spondylitis, Acute Anterior Uveitis and HLA-B27: The Results of a Swiss Family Study 1988 ·Lara D. Veeken ·Sjef M. van der Linden, (unknown), Lynn H. Gerber, A. Cats, H. A. Valkenburg	12
19	De Kaunas-Rotterdam-Intervention Study (KRIS) VI. De resultaten van de dubbelblind trial te Rotterdam 1977 ·Socio-Environmental Systems Modeling ·(unknown), (unknown), H. A. Valkenburg, (unknown), (unknown), (unknown), (unknown)	1
20	The natural history of serum uric acid levels in the relatives of patients suffering from gout 1962 ·Arthritis & Rheumatism ·(unknown), F. Davidson, H. A. Valkenburg, (unknown), James V. Neel, Ivan F. Duff	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact